Spaceflight osteoporosis: current state and future perspective

Area of Science:

• Space medicine
• Orthopedics
• Bone physiology

Background:

• Long-duration spaceflight causes significant bone loss in astronauts, a major health concern upon return to Earth.
• Astronauts lose bone mass at a rate far exceeding that of postmenopausal women on Earth.
• Current countermeasures like exercise and supplementation are inadequate for maintaining bone homeostasis.

Purpose of the Study:

• To describe existing countermeasures for spaceflight-induced bone loss.
• To review established osteoporosis treatments used on Earth that could be adapted for astronauts.
• To explore recent advancements in cellular and molecular bone biology for future therapeutic targets.

Main Methods:

• Review of current spaceflight bone loss countermeasures.
• Analysis of pharmacological and non-pharmacological osteoporosis treatments used on Earth.
• Synthesis of current research on cellular and molecular mechanisms of bone homeostasis.

Main Results:

• Existing countermeasures (exercise, supplementation) are insufficient to prevent significant bone loss.
• Established Earth-based osteoporosis treatments show potential for astronaut application.
• Understanding of bone biology is advancing, paving the way for new therapies.

Conclusions:

• Exercise and supplementation alone do not maintain bone health during long space missions.
• Pharmacological treatments for osteoporosis on Earth could be rapidly implemented for astronauts.
• Future targeted therapies based on cellular and molecular bone regulation are promising for mitigating spaceflight-induced bone loss.